Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans

Susann H. Krake, Pablo David G. Martinez, Jenna McLaren, Eileen Ryan, Gong Chen, Karen White, Susan A. Charman, Simon Campbell, Paul Willis, Luiz Carlos Dias

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Phenotypic HTS campaigns with a blood stage malaria assay have been used to discover novel chemotypes for malaria treatment with potential alternative mechanisms of action compared to existing agents. N1-(5-(3-Chloro-4-fluorophenyl)furan-2-yl)-N3,N3-dimethylpropane-1,3-diamine, 1 was identified as a modest inhibitor of P. falciparum NF54 (IC50 = 875 nM) with an apparent long plasma half-life after high dose oral administration to mice, although the compound later showed poor metabolic stability in liver microsomes through ring- and side chain-oxidation and N-dealkylation. We describe here the synthesis of derivatives of 1, exploring the influence of substitution patterns around the aromatic ring, variations on the alkyl chain and modifications in the core heterocycle, in order to probe potency and metabolic stability, where 4k showed a long half-life in rats.

Original languageEnglish
Pages (from-to)929-936
Number of pages8
JournalEuropean Journal of Medicinal Chemistry
Volume126
DOIs
Publication statusPublished - 27 Jan 2017

Keywords

  • Diamines
  • Furan
  • Malaria
  • nM inhibitors
  • Synthesis

Cite this

Krake, S. H., Martinez, P. D. G., McLaren, J., Ryan, E., Chen, G., White, K., ... Dias, L. C. (2017). Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans. European Journal of Medicinal Chemistry, 126, 929-936. https://doi.org/10.1016/j.ejmech.2016.12.024
Krake, Susann H. ; Martinez, Pablo David G. ; McLaren, Jenna ; Ryan, Eileen ; Chen, Gong ; White, Karen ; Charman, Susan A. ; Campbell, Simon ; Willis, Paul ; Dias, Luiz Carlos. / Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans. In: European Journal of Medicinal Chemistry. 2017 ; Vol. 126. pp. 929-936.
@article{91f8ac29bde6498687e732f57d0dbac3,
title = "Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans",
abstract = "Phenotypic HTS campaigns with a blood stage malaria assay have been used to discover novel chemotypes for malaria treatment with potential alternative mechanisms of action compared to existing agents. N1-(5-(3-Chloro-4-fluorophenyl)furan-2-yl)-N3,N3-dimethylpropane-1,3-diamine, 1 was identified as a modest inhibitor of P. falciparum NF54 (IC50 = 875 nM) with an apparent long plasma half-life after high dose oral administration to mice, although the compound later showed poor metabolic stability in liver microsomes through ring- and side chain-oxidation and N-dealkylation. We describe here the synthesis of derivatives of 1, exploring the influence of substitution patterns around the aromatic ring, variations on the alkyl chain and modifications in the core heterocycle, in order to probe potency and metabolic stability, where 4k showed a long half-life in rats.",
keywords = "Diamines, Furan, Malaria, nM inhibitors, Synthesis",
author = "Krake, {Susann H.} and Martinez, {Pablo David G.} and Jenna McLaren and Eileen Ryan and Gong Chen and Karen White and Charman, {Susan A.} and Simon Campbell and Paul Willis and Dias, {Luiz Carlos}",
year = "2017",
month = "1",
day = "27",
doi = "10.1016/j.ejmech.2016.12.024",
language = "English",
volume = "126",
pages = "929--936",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier",

}

Krake, SH, Martinez, PDG, McLaren, J, Ryan, E, Chen, G, White, K, Charman, SA, Campbell, S, Willis, P & Dias, LC 2017, 'Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans' European Journal of Medicinal Chemistry, vol. 126, pp. 929-936. https://doi.org/10.1016/j.ejmech.2016.12.024

Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans. / Krake, Susann H.; Martinez, Pablo David G.; McLaren, Jenna; Ryan, Eileen; Chen, Gong; White, Karen; Charman, Susan A.; Campbell, Simon; Willis, Paul; Dias, Luiz Carlos.

In: European Journal of Medicinal Chemistry, Vol. 126, 27.01.2017, p. 929-936.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans

AU - Krake, Susann H.

AU - Martinez, Pablo David G.

AU - McLaren, Jenna

AU - Ryan, Eileen

AU - Chen, Gong

AU - White, Karen

AU - Charman, Susan A.

AU - Campbell, Simon

AU - Willis, Paul

AU - Dias, Luiz Carlos

PY - 2017/1/27

Y1 - 2017/1/27

N2 - Phenotypic HTS campaigns with a blood stage malaria assay have been used to discover novel chemotypes for malaria treatment with potential alternative mechanisms of action compared to existing agents. N1-(5-(3-Chloro-4-fluorophenyl)furan-2-yl)-N3,N3-dimethylpropane-1,3-diamine, 1 was identified as a modest inhibitor of P. falciparum NF54 (IC50 = 875 nM) with an apparent long plasma half-life after high dose oral administration to mice, although the compound later showed poor metabolic stability in liver microsomes through ring- and side chain-oxidation and N-dealkylation. We describe here the synthesis of derivatives of 1, exploring the influence of substitution patterns around the aromatic ring, variations on the alkyl chain and modifications in the core heterocycle, in order to probe potency and metabolic stability, where 4k showed a long half-life in rats.

AB - Phenotypic HTS campaigns with a blood stage malaria assay have been used to discover novel chemotypes for malaria treatment with potential alternative mechanisms of action compared to existing agents. N1-(5-(3-Chloro-4-fluorophenyl)furan-2-yl)-N3,N3-dimethylpropane-1,3-diamine, 1 was identified as a modest inhibitor of P. falciparum NF54 (IC50 = 875 nM) with an apparent long plasma half-life after high dose oral administration to mice, although the compound later showed poor metabolic stability in liver microsomes through ring- and side chain-oxidation and N-dealkylation. We describe here the synthesis of derivatives of 1, exploring the influence of substitution patterns around the aromatic ring, variations on the alkyl chain and modifications in the core heterocycle, in order to probe potency and metabolic stability, where 4k showed a long half-life in rats.

KW - Diamines

KW - Furan

KW - Malaria

KW - nM inhibitors

KW - Synthesis

UR - http://www.scopus.com/inward/record.url?scp=85006507588&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2016.12.024

DO - 10.1016/j.ejmech.2016.12.024

M3 - Article

VL - 126

SP - 929

EP - 936

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -